טוען...

Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor.

Inhibitors of the human immunodeficiency virus protease represent a promising new class of antiretroviral drugs for the treatment of AIDS. We now report the in vitro selection of viral variants with decreased sensitivity to a symmetry-based protease inhibitor, ABT-538, currently being tested in clin...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Markowitz, M, Mo, H, Kempf, D J, Norbeck, D W, Bhat, T N, Erickson, J W, Ho, D D
פורמט: Artigo
שפה:Inglês
יצא לאור: 1995
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC188631/
https://ncbi.nlm.nih.gov/pubmed/7815532
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!